Article Details

Innate Pharma : Announces IPH5201 Phase 2 Study in Lung Cancer - Form 6-K

Retrieved on: 2022-06-03 11:11:17

Tags for this article:

Click the tags to see associated articles and topics

Innate Pharma : Announces IPH5201 Phase 2 Study in Lung Cancer - Form 6-K. View article details on HISWAI: https://www.marketscreener.com/quote/stock/INNATE-PHARMA-35620/news/Innate-Pharma-Announces-IPH5201-Phase-2-Study-in-Lung-Cancer-Form-6-K-40630259/

Excerpt

AstraZeneca and Innate will share study costs and AstraZeneca will supply clinical trial drugs. "We are very pleased that our collaboration with ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up